期刊文献+

不同方法治疗阴道上皮内瘤变Ⅱ级合并高危HPV感染的临床疗效分析 被引量:8

Analysis of the clinical effectiveness of different methods of treating gradeⅡvaginal intraepithelial neoplasia and a high-risk HPV infection
原文传递
导出
摘要 目的探讨不同治疗方法对阴道上皮内瘤变Ⅱ级合并高危HPV感染的临床疗效。方法选择2017年3月-2020年7月本院收治的阴道上皮内瘤变(VAIN)Ⅱ级合并高危HPV感染患者300例,随机分为YAG激光治疗组、光动力治疗组和咪喹莫特治疗组,每组100例。于治疗前和治疗后第3、6、12个月各随访1次,记录妇科检查、阴道镜检查、阴道液基细胞学检查、HPV-DNA分型定量检查情况,比较治疗次数、治愈率、复发率、不良反应等。结果实际完成治疗及随访者共251人,其中YAG组100人,光动力组86人,咪喹莫特组65人。治疗次数中位数分别为:YAG激光治疗组1次,光动力治疗组4次,咪喹莫特治疗组48次。治愈率分别为:YAG激光治疗组84.0%、光动力治疗组59.3%、咪喹莫特治疗组76.9%。YAG激光治疗组与咪奎莫特治疗组比较差异无统计学意义(P=0.212),但这两组与光动力组比较差异有统计学意义,且疗效均优于光动力组(P≤0.01)。随访过程中所有患者病情均无进展,复发率分别为:YAG激光治疗组9.0%,光动力治疗组19.8%,咪喹莫特治疗组10.8%,差异无统计学意义P>0.05)。不良反应发生率YAG激光治疗组30.0%,光动力治疗组26.7%,咪喹莫特治疗组56.9%,差异有统计学意义(P<0.05);YAG激光治疗组与光动力治疗组比较不良反应发生率差异无统计学意义(P>0.05)。结论YAG激光和咪喹莫特治疗VAINII伴高危型HPV感染均有良好疗效。 Objective To investigate the clinical effectiveness of different methods of treating gradeⅡvaginal intraepithelial neoplasia(VAINⅡ)and a high-risk HPV infection.Methods Subjects were a total of 300 patients who were diagnosed with VAINII and a high-risk HPV infection and who underwent treatment at this Hospital from March 2017 to July 2020.Patients were randomly divided into a group treated with a YAG laser,a group treated with photodynamic therapy,and a group treated with 5%imiquimod cream.There were 100 patients in each group.Patients were followed up once before treatment and 3,6,and 12 months after treatment.Results of a gynecological examination,ThinPrep cytology,and human papillomavirus(HPV)typing were recorded,and the number of treatments,the cure rate,the rate of recurrence,and adverse reactions were compared.Results A total of 251 patients completed the treatment and were interviewed,including 100 in the YAG group,86 in the photodynamic therapy group,and 65 in the imiquimod group.The cure rate in the three groups was 84.0%in the YAG laser treatment group,59.3%in the photodynamic therapy group,and 76.9%in the imiquimod group.There were no significant differences in the cure rate between the YAG laser treatment group and the imiquimod group(P=0.212),but the cure rate differed significantly in the two groups compared to that in the photodynamic therapy group(P<0.01).Treatment was more effective than that in the photodynamic therapy group.During follow-up,there was no disease progression in any of the patients,and the rate of recurrence was 9%in the YAG laser treatment group,19.8%in the photodynamic therapy group,and 10.8%in the imiquimod group.The rate of recurrence did not differ significantly among the three groups(P>0.05).The incidence of adverse reactions was 30%in the YAG laser treatment group,26.7%in the photodynamic therapy group,and 56.9%in the imiquimod group.The incidence of adverse reactions in the imiquimod group was higher than that in the other two groups(the difference was significant)but the incidence of adverse reactions did not differ significantly in the other two groups.Conclusion Both YAG laser treatment and imiquimod were effective in patients with VAINII and a high-risk HPV infection.
作者 徐晶 屈清华 刘宝 颜丽 申丽媛 杨君 XU Jing;QU Qing-hua;LIU Bao;YAN Li;SHEN Li-yuan;YANG Jun(Chongqing Special Department of Cervical Disease,Chongqing Maternal and Child Health Hospital,Chongqing 400013,China)
出处 《中国病原生物学杂志》 CSCD 北大核心 2021年第12期1470-1473,共4页 Journal of Pathogen Biology
基金 重庆市科卫联合医学科研项目(No.2018QNM027) 重庆市科卫联合重点项目(No.2019ZDXM051)。
关键词 阴道上皮内瘤变 人乳头瘤病毒 激光 咪喹莫特 光动力治疗 vaginal intraepithelial neoplasia human papillomavirus laser imiquimod cream photodynamic therapy
  • 相关文献

参考文献8

二级参考文献52

  • 1顾恒,曾凡钦,郭在培,彭振辉,毕志刚,朱学骏,陈昆,郭庆,张谊之,闫乎铃,张美华,韩钢文,常宝珠,刘训荃(指导),王家璧(指导).咪喹莫特乳膏治疗尖锐湿疣随机、双盲、多中心研究[J].中华皮肤科杂志,2003,36(9):501-504. 被引量:96
  • 2沈春花,骆丹.咪喹莫特治疗皮肤肿瘤的研究进展[J].国际皮肤性病学杂志,2007,33(1):22-24. 被引量:2
  • 3陈江,何春涤.咪喹莫特抗皮肤肿瘤的作用机制[J].国际皮肤性病学杂志,2007,33(3):136-138. 被引量:1
  • 4Barzon L, Pizzighella S, Corti L, Mengoli C, Pal G. Vaginal dysplastic lesions in women with hysterectomy and receiving radiotherapy are linked to high-risk human papillomavirus. J Med Virol 2002; 67: 401-405.
  • 5Srodon M, Stoler MH, Baber GB, Kurman RJ. The distribution of low and high-risk HPV types in vulvar and vaginal intraepithelial neoplasia (VIN and VAIN). Am J Surg Pathol 2006; 30: 1513-1518.
  • 6Sugase M, Matsukura T. Distinct manifestations of human papillomaviruses in the vagina. Int J Cancer 1997; 72:412-415.
  • 7Gonzilez Bosquet E, Torres A, Busquets M, Esteva C, Mufioz-Almagro C, Lailla JM. Prognostic factors for the development of vaginal intraepithelial neoplasia. Eur J Gynaecol Oncol 2008; 29: 43-45.
  • 8Frega A, French D, Piazze J, Cerekja A, Vetrano G, Moscarini M. Prediction of persistent vaginal intraepithelial neoplasia in previously hysterectomized women by high-risk HPV DNA detection. Cancer Lett 2007; 249: 235-241.
  • 9Josefsson AM, Magnusson PK, Ylitalo N, S0rensen P, Qwarforth-Tubbin P, Andersen PK, et al. Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study. Lancet 2000; 355: 2189-2193.
  • 10Schlecht NF, Trevisan A, Duarte-Franco E, Rohan TE, Ferenczy A, Villa LL, et al. Viral load as a predictor of the risk of cervical intraepithelial neoplasia. Int J Cancer 2003; 103: 519-524.

共引文献51

同被引文献92

引证文献8

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部